from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2702/ppgK

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

-0.091

Cap5-10ug/mL Capreomycintranslation

0.674

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.011

Rif0.2-5ug/mL Rifampicintranscription

1.157

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.297

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.103

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.420

CPZ10-50 ug/mL Chlorpromazinerespiration

0.726

Clofazimine10-13 ug/mL Clofaziminerespiration

0.799

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.979

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.206

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.483

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.282

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.080

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.495

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.666

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.363

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.070

KCN5-20 ug/mL Potassium cyaniderespiration

-0.246

NaN30.2-2 mM Sodium aziderespiration

-1.691

Nigericin50 uM Nigericinrespiration

0.773

TRC10-150 ug/mL Triclosanrespiration

0.325

TRZ10-25 ug/mL Thioridazinerespiration

0.204

Valinomycin0.5-10 uM Valinomycinrespiration

-1.122

ZnSO42 mM ZnSO4respiration

-1.066

menadione6-10 ug/mL Menadionerespiration

0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.711

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.755

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.920

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.080

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.116

Cephalexin20-100 ug/mL CephalexincellWall

1.805

Cerulenin0.32-5 ug/mL CerulenincellWall

0.067

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.103

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.434

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.255

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.018

BZA0.12 mg/mL BenzamidearomaticAmides

0.295

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.255

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.664

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.050

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.335

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.219

UVUV-irradiationDNAdamaging

0.468

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.544

Antimycin12.5-50 ug/mL Antimycin A?

-2.021

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.000

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.594

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.440

PA8240.2-2 ug/mL PA-824?

0.343

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.356

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.591

Verapamil50 uM Verapamil?

-2.305

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.301

methoxatin10-20 ug/mL Methoxatin?